Roberto Marchioli
IQVIA (United Kingdom) · 63 works · 7,295 citations · h-index 25
Top works
- Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- Cardiovascular Events and Intensity of Treatment in Polycythemia Vera
- Chronic Myeloproliferative Disorders
- Measuring Plasma Fibrinogen to Predict Stroke and Myocardial Infarction
- Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations; GISSI-Prevenzione mortality risk chart
- Antioxidant vitamins and prevention of cardiovascular disease: Epidemiological and clinical trial data
- Meta-analysis, Clinical Trials, and Transferability of Research Results Into Practice
- Mechanisms of Bleeding and Thrombosis in Myeloproliferative Disorders
- Metabolic Syndrome and Risk of Cardiovascular Events After Myocardial Infarction
- Left Ventricular Systolic Dysfunction, Total Mortality, and Sudden Death in Patients with Myocardial Infarction Treated with n-3 Polyunsaturated Fatty Acids
- Predictors of Mortality in 6975 Patients With Chronic Heart Failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure Trial
- Sheffield risk and treatment table for cholesterol lowering in prevention of coronary heart disease. GISSI-Prevenzione Investigators.
- Beneficial effects of statins
- A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)–Prevenzione scoring
- The results of the GISSI-Prevenzione trial in the general framework of secondary prevention
- Coffee Consumption and Risk of Cardiovascular Events After Acute Myocardial Infarction
- From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.
- GlObal Secondary Prevention strategiEs to Limit event recurrence after myocardial infarction: the GOSPEL study. A trial from the Italian Cardiac Rehabilitation Network: rationale and design
- Bedside monitoring of antiplatelet therapy for coronary stenting.